Specialized MIDx Target BioCentra's molecular infectious disease testing capabilities to position complementary infectious disease panels and high-complexity workflows for clinical labs seeking scalable MIDx services.

Pharmacogenomics Focus Leverage their PGx offerings to propose pharmacogenomics integration and companion diagnostic collaborations with pharma and EMR-enabled precision medicine programs.

Texas Footprint Align sales outreach around Texas-based laboratory markets and clinical partners, offering scalable CLIA-compliant testing, privacy-compliant data sharing, and local onboarding support.

High-Complexity Capabilities Emphasize relationship-building with decision-makers at hospitals and reference laboratories that require high-complexity testing, offering turnkey validation, automation, and turn-around-time improvements.

Growing Revenue Potential Position as a nimble, private-labeled or co-branded testing partner to capture incremental revenue opportunities as they scale beyond the current mid-market revenue band.